The innovative clinical-stage immunotherapy company highlighted in today’s article has a slew of bullish indicators, suggesting it’s gearing up for a surge – and the author outlines one trade idea for this stock that offers upside potential of 41% to 124% in the next four to six months. For the stock in question, the bullish indicators and the details of the recommended trade, CLICK HERE.
![](https://www.hotstockanalyst.com/wp-content/uploads/2020/06/2020-06-23-21_53_09-Person-Holding-A-Vaccine-·-Free-Stock-Photo.png)